Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and efficacy study of rhAngiostatin administered in combination with paclitaxel and carboplatin to patients with non-small-cell lung cancer

Next Previous
Trial Profile

Safety and efficacy study of rhAngiostatin administered in combination with paclitaxel and carboplatin to patients with non-small-cell lung cancer

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 03 Nov 2006

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Angiostatin (Primary) ; Carboplatin; Paclitaxel
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors EntreMed

Most Recent Events

  • 03 Nov 2006 Status change
  • 10 Aug 2005 New trial record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top